CTCF-binding elements 1 and 2 in the Igh intergenic control region cooperatively regulate V(D)J recombination
See allHide authors and affiliations
Contributed by Frederick W. Alt, December 30, 2014 (sent for review December 22, 2014; reviewed by Cornelis Murre, Eugene Oltz, and David G. Schatz)

Significance
Mice and humans generate diverse antibody repertoires through a genomic rearrangement process termed “V(D)J recombination” that assembles genetic regions that encode antigen-binding portions of antibodies by cutting and pasting together different combinations of V, D, and J gene segments. V(D)J recombination is strictly controlled to ensure generating a sufficiently large antibody repertoire to recognize any pathogen encountered and to minimize generation of self-reactive antibodies. Across the large antibody heavy-chain locus, V(D)J recombination regulation depends on a small control region, intergenic control region 1 (IGCR1), containing two CCCTC-binding factor–binding elements (CBEs) that bind a broadly expressed factor implicated in chromosomal looping. The current studies show that these two CBEs function cooperatively to mediate full IGCR1 functions and suggest a working model for how they do so.
Abstract
Ig heavy chain (IgH) variable region exons are assembled from V, D, and J gene segments during early B-lymphocyte differentiation. A several megabase region at the “distal” end of the mouse IgH locus (Igh) contains hundreds of VHs, separated by an intergenic region from Igh Ds, JHs, and constant region exons. Diverse primary Igh repertoires are generated by joining Vs, Ds, and Js in different combinations, with a given B cell productively assembling only one combination. The intergenic control region 1 (IGCR1) in the VH-to-D intergenic region regulates Igh V(D)J recombination in the contexts of developmental order, lineage specificity, and feedback from productive rearrangements. IGCR1 also diversifies IgH repertoires by balancing proximal and distal VH use. IGCR1 functions in all these regulatory contexts by suppressing predominant rearrangement of D-proximal VHs. Such IGCR1 functions were neutralized by simultaneous mutation of two CCCTC-binding factor (CTCF)-binding elements (CBE1 and CBE2) within it. However, it was unknown whether only one CBE mediates IGCR1 functions or whether both function in this context. To address these questions, we generated mice in which either IGCR1 CBE1 or CBE2 was replaced with scrambled sequences that do not bind CTCF. We found that inactivation of CBE1 or CBE2 individually led to only partial impairment of various IGCR1 functions relative to the far greater effects of inactivating both binding elements simultaneously, demonstrating that they function cooperatively to achieve full IGCR1 regulatory activity. Based on these and other findings, we propose an orientation-specific looping model for synergistic CBE1 and CBE2 functions.
The B-lymphocyte antigen receptor (BCR) is made of Ig heavy (IgH) and light (IgL) chains. T cells recognize antigen through related T-cell receptors (TCRs). The N-terminal variable regions of Ig and TCR chains form the antigen-binding site. Each B cell expresses a single unique antigen receptor. However, there is an immense diversity of different antigen receptors expressed population-wide in different B cells, a phenomenon that relies on the assembly of exons that encode variable regions from germline V, D, and J gene segments (“Vs,” “Ds,” and “Js”) during early B- and T-cell development (1). V(D)J recombination at both Ig and TCR loci is carried out by a common V(D)J “recombinase.” Recombination activating genes 1 and 3 (RAG1 and RAG2) comprise the lymphocyte-specific endonuclease (“RAG”) that initiates V(D)J recombination by generating DNA double-strand breaks at recombination signal sequences (RSSs) adjacent to participating Vs, Ds, and Js (2). Subsequently, RAG-cleaved segments are joined by classical nonhomologous end-joining (3).
In B cells, V(D)J exons are assembled within the IgH locus (Igh) and within either of two Igl loci (Igκ or Igλ). The murine Igh spans 3 Mb on chromosome 12 (Fig. 1). Approximately 150 VHs are scattered within a 2.7-Mb upstream portion of Igh, followed by a 100-kb intergenic region that separates the most downstream VH (VH81X) from the first of 13 Ds (4). Four JHs lie downstream of the Ds and are separated from the first of eight sets of IgH constant region exons by a several-kilobase region that harbors the intronic Igh enhancer (iEμ). A second set of enhancers within the Igh 3′ regulatory region (3′ Igh RR) lies ∼200 kb downstream, just beyond the last set of CH exons (5). V(D)J recombination at Igh is regulated on multiple levels, in each case by modulating the accessibility of the substrate Vs, Ds, and Js and their flanking RSSs to RAG cleavage (6, 7). In this regard, Igh V(D)J recombination events are ordered and are stage specific; D-to-JH joining occurs first, usually on both alleles, in preprogenitor B cells, followed by the joining of a VH to a preassembled DJH complex in progenitor B (pro-B) cells (8, 9). In addition, V(D)J recombination is lineage specific; thus, although both developing B and T cells generate Igh DJH joins, complete VHDJH joins only occur in B cells (10, 11). Finally, V(D)J recombination is feedback regulated in the context of allelic exclusion, with productive VHDJH rearrangements that lead to IgH chain production inhibiting VH-to-DJH recombination events on the other DJH allele in developing B cells (8, 12).
Mutation of single IGCR1 CBEs. Schematic of the murine Igh locus showing the IGCR1 region in WT relative to IGCR1/CBE1-mutated and IGCR1/CBE2-mutated configurations. Symbols are indicated on the figure. CBE orientation is indicated by the direction of the pink arrowheads (see the Introduction for details).
In the context of the regulatory events outlined above, accessibility of particular RSSs to RAG cleavage correlates with various factors, including germline transcription of target gene segments and certain chromatin modifications (9, 13). Normal Igh V(D)J recombination also depends on iEμ, although residual V(D)J recombination in the absence of this element implicates additional cis elements (14, 15). In addition, regulatory factors such as Pax5 and Yin Yang 1 (YY1), which bind to sites throughout Igh, participate in a locus-contraction process that brings distal VHs closer to DJH joins subsequent to their formation to promote a more diverse set of primary V(D)J rearrangements (16⇓–18). During B-cell development, cells deficient for such factors fail to undergo Igh locus contraction and, as a result, predominantly rearrange D-proximal VHs versus distal VHs (16, 18). Notably, the most D-proximal VH, VH81X, is used preferentially during primary VH-to-DJH rearrangements even in normal pro-B cells (19, 20). However, productive VH81X rearrangements are counter selected because of autoreactivity and poor pairing with IgL chains, greatly reducing their representation in antibody repertoires (21).
Many aspects of Igh V(D)J recombination regulation, including order, lineage specificity, and feedback control, as well as the balanced use of proximal and distal VHs, depend on the integrity of the intragenic control region 1 (IGCR1), which, as a working definition, was ascribed to a 4.1-kb DNA segment within the 100-kb VH81X-to-D intragenic region (22). Moreover, known IGCR1 functions depend on the integrity of two 20-bp CCCTC-binding factor (CTCF)-binding elements (CBEs), termed “CBE1” (upstream) and “CBE2” (downstream) (Fig. 1), that are separated by about 2 kb within IGCR1 (22, 23). CTCF is a highly conserved zinc-finger protein with diverse roles in gene regulation, including promoter activation/repression, long-range chromosome interactions, and insulating activity (24). Roles for IGCR1 and the two IGCR1 CBEs in regulating Igh V(D)J recombination were discovered by the common phenotypes of mice in which either the 4.1-kb IGCR1 segment was deleted or in which IGCR1 CBEs within this segment were simultaneously replaced with scrambled sequences (to generate IGCR1/CBE1&2−/− alleles) that do not bind CTCF (22). Both types of mutant mice displayed increased germline transcription and premature rearrangement of VH81X and, to a lesser extent, several closely linked VHs on mutant alleles, leading to breaks in ordered, lineage-specific, and feedback-regulated Igh V(D)J recombination (22). Thus, IGCR1, via a process that requires one or both CBEs, promotes diverse antibody repertoires by preventing premature proximal VH rearrangement, which can deplete DJH substrates for distal VH joining subsequent to locus contraction.
The Igh has a large number of CBEs with a strikingly suggestive organization (Fig. 1 and Fig. S1) (9, 17, 22). In this regard, CBEs lie just downstream of most proximal VH RSSs or are dispersed among distal VH clusters (25, 26). In addition there is a cluster of 10 CBEs termed the “3′ CBEs” just downstream of the Igh 3′ RR (27). The IGCR1 locale interacts with the 3′ CBEs and with some VH CBEs in a manner dependent on the integrity of its CBEs (22, 28). This body of findings led to proposals that interaction of the IGCR1 CBEs with 3′ CBEs or other downstream elements may sequester the D-to-JH portion of Igh in a loop that contains iEμ and the 3′ Igh RR and/or other elements to promote D-to-JH recombination and that such loops exclude transcriptional activation and rearrangement of proximal VHs (9, 26, 29). Interaction of IGCR1 CBEs with upstream VH-associated CBEs also is speculated to play a positive role in promoting VH-to-DJH pairing for V(D)J recombination (17, 30).
To elucidate potential roles for CBE1, CBE2, or both with respect to known IGCR1 functions in V(D)J recombination, we now have generated and analyzed mice in which one or the other IGCR1 CBE was individually replaced with scrambled sequence mutations.
Results
Replacement of CBE1 or CBE2 in Mice with a Scrambled Control Sequence.
To determine whether the two CBEs within IGCR1 have overlapping, distinct, or redundant roles in Igh V(D)J recombination control, we introduced a scrambled sequence that has no CTCF binding activity (22) into 129SV ES cells, either in place of the CBE1 sequence to generate an IGCR1/CBE1− allele or in place of CBE2 to generate an IGCR1/CBE2− allele. We then introduced these two mutations into the 129SV mouse germline to assay potential effects on the control of V(D)J recombination (Fig. 1 and Fig. S2). Based on our gene-targeted replacement strategy, both IGCR1/CBE1− and IGCR1/CBE2− alleles retain an inserted loxP site after cre-mediated deletion of a neomycin-resistance selection cassette. However, our prior studies confirmed that control mice with a WT IGCR1, but which contain the upstream loxP site, were indistinguishable from WT mice with respect to Igh V(D)J recombination control (22).
Roles of IGCR1 CBE1 Versus CBE2 in B-Cell Development.
Bone marrow (BM) pro-B cells undergo VH-to-DJH rearrangements, which, if productive (in-frame), generate μ IgH chains that signal proliferation and progression to the precursor (pre) B-cell stage in which assembly of the Igl variable region exon occurs (1). Productive Igl rearrangements produce an IgL chain that can combine with the μ IgH chain to form a surface BCR and can lead to differentiation of B cells that migrate to peripheral lymphoid organs such as the spleen. To probe for B-cell developmental defects associated with the mutant Igh alleles, we bred 129SV strain mice (which express the IgMa allotype) harboring either the IGCR1/CBE1− or the IGCR1/CBE2− allele with C57BL/6 mice (which express the IgMb allotype) to generate F1 mice that harbor a WT Igmb allele and either an IGCR1/CBE1− or an IGCR1/CBE2− Igma allele. These F1 mice were assayed for the proportion of BM and splenic IgM+ B cells that express surface IgMa versus IgMb. F1 mice with WT alleles have roughly equal numbers of IgMa- and IgMb-expressing B cells in BM or the spleen, because there is an equal chance of forming a productive rearrangement on both alleles and because of the phenomenon of allelic exclusion (Fig. 2 and Fig. S3 A and B) (1, 9). However, although mice harboring the IGCR1/CBE2− Igha allele were indistinguishable from WT mice with respect to IgMa versus IgMb expression, mice harboring the IGCR1/CBE1− Igha allele had only half as many IgMa-expressing as IgMb-expressing B cells (Fig. 2 and Fig. S3 A and B), despite having similar total numbers of splenic B cells (Fig. S3C). Although mutation of IGCR1 CBE1 had a greater impact than mutation of IGCR1 CBE2 on the ability of an Igh allele to support B-cell development, the defect was not nearly as severe as that observed for IgMa/b F1 mice in which both IGCR1 CBEs were mutated simultaneously on the IgMa allele (22).
Effect of IGCR1/CBE mutations on B-cell development. IgMb:IgMa expression ratios of IgMa and IgMb allotypic markers in BM (A) and spleen (B) from WT F1 IgMa/IgMb mice [BM: mean (m) = 1.08 ± 0.0502, n = 12; spleen: m = 0.857 ± 0.0196, n = 11], heterozygous mutant IGCR1/CBE1− IgMa/WT IgMb mice (BM: m = 2.79 ± 0.108, n = 5; spleen: m = 1.904 ± 0.128, n = 5), and IGCR1/CBE2− IgMa/ WT IgMb mice (BM: m = 1.22 ± 0.086, n = 3; spleen: m = 0.94 ± 0.032, n = 3). Horizontal lines and whickers indicate mean and SEM. P values were generated by unpaired Student’s t test. Each data point was collected from different 4- to 6-wk-old mice; at least three mice were used for each genotype.
Roles of IGCR1 CBE1 Versus CBE2 in Generation of the Igh V(D)J Repertoire.
We used a PCR-Southern approach (22) to assay for proximal (VH7183) and distal (VHJ558) VH-to-DJH rearrangements in pro-B and pre-B cells of WT and mutant mice. Primers for either the proximal VH7183 family or the distal VHJ558 family were paired with a primer downstream of JH4. PCR products were run on a gel, probed with a 32P-labeled oligo that bound a region between JH3 and JH4, and then were exposed via autoradiography. The mouse Dlg5 gene was used as a loading control. The IGCR1/CBE2−/− pro-B cells and, even more so, IGCR1/CBE1−/− pro-B cells displayed increased VH7183- versus VHJ558-to-DJH rearrangements compared with WT, but not nearly to the extent observed in IGCR1/CBE1&2−/− pro-B cells, with VH7183/VHJ558 ratios averaging ∼1/1, 10/1, 3/1, and 40/1 for WT, IGCR1/CBE1−/−, IGCR1/CBE2−/−, and IGCR1/CBE1&2−/− pro-B cells, respectively (three representative experiments are shown in Fig. 3A). Similar comparative analyses of WT pre-B cells among the WT and various CBE-mutant pre-B cells indicated much more modest differences in VH7183/VHJ558 utilization ratios (Fig. S4A), likely because of selective expansion of pre-B cells expressing more distal VH rearrangements, as discussed previously (22).
IGCR1/CBE1 and IGCR1/CBE2 mutations alter proximal VH use and ordered rearrangement. (A) PCR analyses of the VH7183, VHJ558 VH family V(D)J rearrangements in pro-B cells from indicated mice. Data from three independent experiments, each using a different mouse, are shown. The Dlg5 lanes represent a loading control. The same starting DNA was assayed for each sample, along with two fivefold serial dilutions. Bands from the VHDJH products contain JH1, JH2, and JH3 rearrangements, respectively, from largest to smallest products. We calculated by inspection the approximate use of VH7183 relative to VHJ558 for each sample in a given set based on signals obtained with the 1×, 5×, and 25× dilutions and then expressed the relative values for each sample from a given type of mutant pro-B cells relative to that of the WT sample which was set as 1 (shown at the bottom of the panels for each experimental set). This approach is analogous to one we have described previously (19, 20). (B) We used PCR to assay for direct VH81X-to-DHQ52 rearrangements using the same three sets of DNA samples (and dilutions) as described for A; thus, the DLG5 loading controls in A and B are identical for each set of repeats.
Roles of IGCR1 CBE1 Versus CBE2 in Ordered Rearrangement.
Our previous studies on the IGCR1−/− and IGCR1/CBE1&2−/− mice revealed a break in ordered V(D)J recombination, with VH-to-D rearrangements often preceding D-to-JH rearrangements (22). Thus, we sought to determine whether one or both of the IGCR1 CBEs are required for maintaining ordered rearrangement. For this purpose, we assayed for direct VH-to-D joins by using a forward VH81X primer with a reverse primer located between DQ52 and JH1. By this method, we clearly detected direct VH–D joins in both pro-B and pre-B cells in the IGCR1/CBE1−/− mice, albeit to a substantially lesser extent than observed in the IGCR1/CBE1&2−/− mutants (Fig. 3B and Fig. S4B). We also observed a variable increase in direct VH81X-to-DQ52 joins in IGCR1/CBE2−/− mutants (Fig. 3B and Fig. S4B). Thus, both CBE1 and CBE2 appear to be required for fully maintaining ordered Igh V(D)J recombination, with disordered rearrangement occurring more abundantly when both are mutated.
Roles of CBE1 Versus CBE2 in Maintaining Lineage-Specific VH-to-DJH Rearrangement.
We used the PCR-based assay described above to assay for VH-to-DJH rearrangements in developing thymic T cells. A PCR assay for Igl Vκ–Jκ joins confirmed low to no detectable B-cell contamination in the CD4+/CD8+ thymocyte samples; WT splenic B-cell DNA served as a positive control (three representative experiments are shown in Fig. 4). These analyses clearly revealed complete VH7183-to-DJH but not VHJ558-to-DJH joins in both IGCR1/CBE1−/− and IGCR1/CBE2−/− thymocytes, albeit in either case not nearly to the same extent as when both of the CBEs were mutated simultaneously (Fig. 4). We also assayed for direct VH81X-to-DQ52 joins in CD4+/CD8+ T cells from WT, IGCR1/CBE1−/−, IGCR1/CBE2−/−, and IGCR1/CBE1&2−/− mutants and detected direct joins in the IGCR1/CBE1−/− and, to a lesser extent, in IGCR1/CBE2−/− thymocytes, albeit again in both cases at substantially lower levels than observed in IGCR1/CBE1&2−/− mutant thymocytes (Fig. S5). Thus, CBE1 and CBE2 also appear to function cooperatively to maintain lineage-specific proximal VH rearrangements.
IGCR1/CBE1 and IGCR1/CBE2 mutations deregulate IgH V(D)J recombination in thymocytes. PCR analyses of Igh VH7183 and VHJ558 family V(D)J rearrangements in CD4+CD8+ thymocytes from indicated mice. The VκJκ panels are controls for potential B-cell contamination, and the Dlg5 lanes represent a loading control. The 1x, 5x, and 25x serial dilutions were assayed for each sample as described in Fig. 3. Bands from the VHDJH products are as described in Fig. 3. Each type of PCR for all three panels of samples was done at the same time and run on the same gel together with the WT splenic B-cell control, which is shown only in the top panel. Three independent experiments, each from a different mouse, are shown. We also used PCR analyses for direct VH81X-to-DQ52 rearrangement in CD4+CD8+ thymocytes from this same set of samples (shown in Fig. S5).
Roles of IGCR1, CBE1, and CBE2 in Feedback-Regulated VH-to-DJH Recombination.
Surface staining of IgM+ splenic B cells from F1 mice containing a WT Igmb allele and a IGCR1/CBE1− or a IGCR1/CBE2− Igma allele did not reveal IgMaIgMb double-expressing cells, indicating that neither mutation leads to a detectable break in allelic exclusion (Fig. S3B). This finding is consistent with the prior observation that the IGCR1/CBE1&2− IgMa allele in this F1 background did not break allelic exclusion (22). On the other hand, prior studies showed that IGCR1/CBE1&2− IgMa VH-to-DJH rearrangements were not suppressed by a productive VHDJH knockin (VB1-8 KI) on the other Igh allele (22). Thus, we similarly assayed for the ability of a VB1-8 KI allele to suppress VH-to-DJH rearrangements on IGCR1/CBE1− and IGCR1/CBE2− Igh alleles. As expected (22), only very low levels of proximal VH7183DJH rearrangements were detected in splenic B cells from VB1-8 KI mice in which the second allele was WT (Fig. 5). In contrast, we observed increased VH7183DJH rearrangements in splenic B cells from VB1-8 KI mice in which the second Igh allele harbored the IGCR1/CBE2− mutation and an even greater increase in those in which the second allele harbored the IGCR1/CBE1− mutation (Fig. 5). Nucleotide sequencing showed that VHDJH rearrangements on the IGCR1/CBE1− allele were predominantly nonproductive VH81X rearrangements (Fig. S6), consistent with patterns observed in IGCR1/CBE1&2− mutants in this experimental setting (22). Rearrangements from the IGCR1/CBE2− alleles also were nonproductive; but in the limited dataset analyzed appeared to involve a wider range of VH7183 segments (Fig. S6). Thus, CBE1 also appears to play a more major role in enforcing feedback regulation of proximal VHs than CBE2, but both together contribute to achieving WT levels. Finally, consistent with previous observations in IGCR1/CBE1&2−/− mice (22), distal VHJ558 segments on IGCR1/CBE1− and IGCR1/CBE2− alleles were still feedback regulated by the VB1-8 KI allele (Fig. 5).
IGCR1/CBE1 and CBE2 are both required for feedback regulation of proximal VH-to-DJH recombination. VHDJH rearrangements in pre-B and splenic B cells from VB1-8 knockin mice in which the second Igh allele was WT, IGCR1/CBE1− (CBE1−), or IGCR1/CBE2− (CBE2−). The 1×, 5×, and 25× serial dilutions were performed for each sample. Other details are as described for Fig. 3.
Discussion
Our analyses of mice that harbor scrambled mutations of either IGCR1 CBE1 or CBE2 reveal that the integrity of each, individually, is required to maintain ordered, lineage-specific, and feedback-regulated Igh V(D)J recombination fully, as well as to balance proximal versus distal VH utilization fully. However, simultaneous mutation of both CBE1 and CBE2 has a cooperative, potentially synergistic, effect, leading to greater de-regulation of these various aspects of Igh V(D)J recombination, all of which are thought to result from deregulated rearrangement of proximal VHs to Ds (22). Our previous studies correlated such deregulated Igh V(D)J recombination with increased proximal VH7183 germline transcription in IGCR1−/− or IGCR1/CBE1&2−/− pro-B cells. Correspondingly, analyses of one set of WT, IGCR1/CBE1−/−, IGCR1/CBE2−/−, IGCR1/CBE1&2−/−, and IGCR1−/− RAG2-deficient v-Abl–transformed pro-B lines revealed clearly increased germline VH7183 transcription in IGCR1−/− and IGCR1/CBE1&2−/− lines compared with the WT or single CBE1 or CBE2 mutant lines, consistent with a cooperative effect of IGCR1 CBE1 and CBE2 in suppressing proximal VH transcription (Fig. S7). Consistent with more substantially deregulated rearrangement of proximal VHs (VH81X in particular), we find that IGCR1/CBE1&2−/− pro-B cells have much more markedly increased ratios of proximal (VH7183) to distal (VHJ558) utilization in V(D)J rearrangements than do IGCR1/CBE1−/− or IGCR1/CBE2−/− pro-B cells. In accord with this more greatly impaired ability to generate a balanced primary pro-B Igh V(D)J repertoire (22), IGCR1/CBE1&2− Igh alleles also appear to have a more greatly impaired ability to support normal B-cell development than do Igh alleles in which only CBE1 or CBE2 is mutated.
Despite their cooperative role in maintaining fully normal regulation of Igh V(D)J recombination, mutation of CBE1 alone appears, on average, to have a greater impact on repertoire, order, and feedback regulation in developing B cells than does mutation of CBE2 alone. This difference is manifested clearly in the more substantially impaired ability of CBE1-mutated alleles versus CBE2-mutated alleles to compete with WT alleles in the context of generating IgM-expressing BM or splenic B cells. This more dominant impact of mutating IGCR1 CBE1 versus CBE2 on Igh V(D)J recombination suggests that, functionally, these two CBEs are not fully equivalent, perhaps reflecting the relative extent to which they contribute to the same functions, their contributions to different functions that are only partially redundant, or both. In either case, relative CBE1 versus CBE2 functionality could reflect their position and/or local sequence environment. In the latter context, the CBE1 binding site overlaps with putative YY1 and PU.1 binding elements (22), both of which are also mutated in the IGCR1/CBE1−/− mice. Thus, the more severe phenotype of the IGCR1/CBE1−/− mice also might reflect impaired YY1 or PU.1 binding. Another important difference is that CBE1 and CBE2 lie in different orientations within Igh, with CBE1 sharing the same orientation as the 10 3′ CBEs and CBE2 sharing the same orientation as the ∼60 VH CBEs (Fig. 1 and Figs. S2 and S8).
Because CTCF has orientation-specific binding, we and others have proposed that the unique CBE organization within Igh might reflect orientation-specific CBE roles in regulating V(D)J recombination (9, 17, and supplemental discussion in ref. 22). A recent study demonstrated that the majority of chromatin loops mediated by CTCF and its interacting partner, cohesin, are anchored at pairs of CBEs that face each other on opposite strands in convergent orientation (31). In developing B cells, the IGCR1 CBEs bind both CTCF and cohesin (26, 27) and, with the other CBEs within Igh, could form three classes of convergently oriented CBE pairs: VH-associated CBEs that could convergently pair with IGCR1 CBE1; IGCR1 CBE2 that could convergently pair with the 3′ CBEs; and the VH-associated CBEs that could convergently pair with the 3′ CBEs (Fig. S8). In this regard, the IGCR1 locale interacts with the 3′ CBEs’ locale and with various VH locations (e.g., proximal VHs, distal Pax5-activated intergenic repeat elements) in a manner that was disrupted by simultaneous mutation of IGCR1 CBE1 and CBE2 (22, 28).
Based on our current findings and other findings outlined above, we propose a preliminary working model for IGCR1 CBE1 and CBE2 function (Fig. S8). First, IGCR1/CBE2 may function to regulate Igh V(D)J recombination by contributing to a loop with the convergently oriented 3′ CBEs to sequester Ds, JHs, and Igh enhancers to increase synapsis frequency (9, 29, 32) and, thereby, promote D-to-JH rearrangement and indirectly suppress VH-to-D rearrangement. Second, CBE1 could form a loop with convergently oriented proximal VH-associated CBEs that would sequester them from the downstream enhancers and interactions with the DJH, potentially in part by preventing them from looping with 3′ CBEs. In the context of this model, mutation of CBE2 would partially deregulate VH-to-D recombination by allowing loops between the proximal VHs and 3′ CBEs, which could increase the frequency of VH interaction with enhancers and with D segments, leading to premature RAG cleavage and joining. Potentially, however, the CBE1 loop with VH CBEs would contribute to dampening this effect. On the other hand, mutation of CBE1 might allow VH CBEs to compete with CBE2 for loop formation with the 3′ CBEs, partially deregulating VH-to-D joining. Finally, simultaneous mutation of both IGCR1 CBEs would abrogate both types of proposed IGCR1 CBE functions, thereby leading to more substantial deregulation of proximal VH V(D)J recombination. Of course, other levels of interactions involving additional factors and elements could contribute to these processes (17, 28, 33). In addition, all proposed IGCR1 CBE functions at the D-to-JH rearrangement stage must be neutralized or otherwise circumvented at the VH-to-DJH rearrangement stages (9, 22). Future studies on long-range Igh locus interactions of the IGCR1 locale with other locales in IGCR1/CBE1 or IGCR1/CBE2 mutants along with orientation-specific IGCR1 CBE mutants will contribute to testing this model further or will suggest others. Finally, CBEs may play a similar role in other antigen receptor loci, as suggested by recent studies of the TCRβ locus (34).
Materials and Methods
Generation of IGCR1 CBE-Mutated Mice.
A previously described pLNTK targeting vector containing scrambled mutations of the 20-bp CBE1 (WT sequence: 5′-GCTTCCCCCTTGTGGCCAT-3′; scrambled sequence: 5′-CCTGCTAGCCTTCTCGTCG-3′) and 19-bp CBE2 (WT sequence: 5′-TCTCCACAAGAGGGCAGAA-3′; scrambled sequence: 5′-ACTAGTAAAAAGCGGCCGC-3′) sites within IGCR1 was electroporated into TC1 ES cells. Successfully targeted clones with single CBE1 scrambled or CBE2 scrambled site integration, but not both, were assessed by Southern blot analyses using StuI-digested (13.9 kb untargeted; 10 kb targeted), SpeI-digested (16.3 kb untargeted; 12.7 kb targeted without CBE2 mutation; 11.2 kb with CBE2 mutation), or HindIII/NheI-digested (12.5 kb targeted without CBE1 mutation; 3.1 kb with CBE1 mutation) genomic DNA with appropriate probes (Fig. S2; also see supplementary figures and table in ref. 22). Two independently targeted clones were subjected to adenovirus-mediated Cre deletion to remove the NeoR gene and were injected for germline transmission. Mice were genotyped by PCR. (Primer sequences are given in Table S1.) WT 129/SV and C57BL/6 mice were used for breeding purposes. All animal experiments were performed under protocols approved by the Institutional Animal Care and Use Committee of Boston Children’s Hospital.
Flow Cytometry Analysis.
BM and spleen single-cell suspensions were obtained from 4- to 6-wk-old mice. For IgMb:IgMa ratios, BM and spleen cells were stained with B220-APC or PECy5, IgMa-FITC, and IgMb-PE. B220+ live cells were plotted and gated for IgMa and IgMb populations. Results were expressed as the ratio of the percent IgMb cells to the percent of IgMa cells.
V(D)J Recombination Assays.
Genomic DNA was purified from sorted BM pro-B (IgM−B220+CD43+) and pre-B (IgM−B220+CD43−) cells, splenic mature B (IgM+B220+CD43−) cells, and thymic double-positive T (B220−CD4+CD8+) cells of 4- to 6-wk-old mice. Fivefold serial dilutions of genomic DNA (200 ng, 40 ng, and 8 ng for splenic mature B, pre-B, and thymic double-positive cells; 160 ng, 32 ng, and 6.4 ng for pro-B cells) were used to perform PCR to analyze V(D)J rearrangements. Primers used in this assay are as described in ref. 22. Primers flanking exon 6 of the Dlg5 gene were used as a loading control. Vκ-to-Jκ rearrangement PCRs were performed to assess potential B-cell contamination during double-positive T-cell analysis. PCR products were gel electrophoresed and transferred to determine V(D)J recombination by Southern blotting using radiolabeled oligonucleotide probes (see ref. 22 for sequences) and were visualized by autoradiography on film or photostimulated luminescence using a phosphorimager. Feedback assays, which involved breeding a VB1-8 knockin Igh allele into mice harboring IGCR1/CBE1− or CBE2− alleles, were performed as described previously (22).
RNA Isolation and RT-PCR.
We isolated RNA and performed RT-PCR using 1/20 of the generated cDNA as described previously (22).
Generation of v-Abl–Transformed Pro-B Lines.
RAG2-deficient pro-B v-Abl lines from WT and the various mutant backgrounds were generated as described previously (22).
Acknowledgments
We thank Hye Suk Yoon and Suvi Jain for helpful advice. This work was supported by National Institutes of Health Grant R01 AI020047. F.W.A. is an Investigator of the Howard Hughes Medical Institute. C.G. was supported by a fellowship from the Cancer Research Institute of New York.
Footnotes
↵1S.G.L. and C.G. contributed equally to this work.
- ↵2To whom correspondence should be addressed. Email: alt{at}enders.tch.harvard.edu.
Author contributions: S.G.L., C.G., and F.W.A. designed research; S.G.L., C.G., A.S., and Y.Z. performed research; S.G.L., C.G., and F.W.A. analyzed data; and S.G.L. and F.W.A. wrote the paper.
Reviewers: C.M., University of California, San Diego; E.O., Washington University in St. Louis; and D.G.S., Howard Hughes Medical Institute, Yale University School of Medicine.
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1424936112/-/DCSupplemental.
References
- ↵
- ↵
- ↵.
- Taccioli GE, et al.
- ↵
- ↵
- ↵
- ↵.
- Sleckman BP,
- Oltz EM
- ↵
- ↵
- ↵.
- Fuxa M, et al.
- ↵.
- Bates JG,
- Cado D,
- Nolla H,
- Schlissel MS
- ↵
- ↵
- ↵.
- Perlot T,
- Alt FW,
- Bassing CH,
- Suh H,
- Pinaud E
- ↵.
- Afshar R,
- Pierce S,
- Bolland DJ,
- Corcoran A,
- Oltz EM
- ↵
- ↵
- ↵
- ↵
- ↵.
- Malynn BA,
- Yancopoulos GD,
- Barth JE,
- Bona CA,
- Alt FW
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵.
- Degner SC, et al.
- ↵.
- Degner SC,
- Wong TP,
- Jankevicius G,
- Feeney AJ
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵.
- Majumder K, et al.
Citation Manager Formats
Article Classifications
- Biological Sciences
- Immunology and Inflammation